Health News Headline
Texting Could Help Spread the Word on Teen Health
TUESDAY, Jan. 15 (HealthDay News) -- Healthy lifestyle text messages could help improve teens' eating and exercise habits, a new study suggests.
University of Arizona researchers conducted a one-year trial involving 177 teens in order to find out their preferences for healthy lifestyle text message content, format, style, origin, frequency and mode of delivery.Read entire article...
Some others: Inflaced, Gastrosed, Femcet, Vibal, Esomeprazolo, Tibofem, Unitranxene, Diane, Cuprimine, Auranofin, Persantin, Psymion, ...
Shortage of Drug for Children's Cancer May Have Upped Relapse Rates
WEDNESDAY, Dec. 26 (HealthDay News) -- When a national shortage of a cancer drug that had helped treat children with Hodgkin's lymphoma for decades forced doctors to find a substitute, they thought they had settled on a drug that would work just as well for these young cancer patients.
But a new analysis suggests they were mistaken.
Mechlorethamine, also known as nitrogen mustard, had been part of a common chemotherapy regimen for Hodgkin's since the 1960s, but experts believed the drug cyclophosphamide would perform equally well. The statistics in the analysis tell another story, however, with two-year remission rates dropping from 88 percent to 75 percent after the switch was made.
"We thought this would be an easy substitution. Cyclophosphamide has been used forever for Hodgkin's lymphoma," said analysis co-author Dr. Monica Metzger, an associate member of the department of oncology at St. Jude Children's Research Hospital in Memphis, Tenn. "We thought the equivalent dose would work just as well, but it doesn't work the same in this chemotherapy regimen. More patients relapsed."Read entire article...